160 related articles for article (PubMed ID: 28887166)
1. Dusp14 protects against hepatic ischaemia-reperfusion injury via Tak1 suppression.
Wang X; Mao W; Fang C; Tian S; Zhu X; Yang L; Huang Z; Li H
J Hepatol; 2017 Sep; ():. PubMed ID: 28887166
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte DUSP14 maintains metabolic homeostasis and suppresses inflammation in the liver.
Wang S; Yan ZZ; Yang X; An S; Zhang K; Qi Y; Zheng J; Ji YX; Wang PX; Fang C; Zhu XY; Shen LJ; Yan FJ; Bao R; Tian S; She ZG; Tang YD
Hepatology; 2018 Apr; 67(4):1320-1338. PubMed ID: 29077210
[TBL] [Abstract][Full Text] [Related]
3. Creg in Hepatocytes Ameliorates Liver Ischemia/Reperfusion Injury in a TAK1-Dependent Manner in Mice.
Yang L; Wang W; Wang X; Zhao J; Xiao L; Gui W; Fan H; Xia J; Li Z; Yan J; Alasbahi A; Zhu Q; Hou X
Hepatology; 2019 Jan; 69(1):294-313. PubMed ID: 30076625
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-Specific Peptidase 10 Protects Against Hepatic Ischaemic/Reperfusion Injury via TAK1 Signalling.
Jiangqiao Z; Tianyu W; Zhongbao C; Long Z; Jilin Z; Xiaoxiong M; Tao Q
Front Immunol; 2020; 11():506275. PubMed ID: 33133065
[TBL] [Abstract][Full Text] [Related]
5. Caspase recruitment domain 6 protects against hepatic ischemia/reperfusion injury by suppressing ASK1.
Qin JJ; Mao W; Wang X; Sun P; Cheng D; Tian S; Zhu XY; Yang L; Huang Z; Li H
J Hepatol; 2018 Nov; 69(5):1110-1122. PubMed ID: 29958938
[TBL] [Abstract][Full Text] [Related]
6. USP4 deficiency exacerbates hepatic ischaemia/reperfusion injury via TAK1 signalling.
Zhou J; Qiu T; Wang T; Chen Z; Ma X; Zhang L; Zou J
Clin Sci (Lond); 2019 Jan; 133(2):335-349. PubMed ID: 30622220
[TBL] [Abstract][Full Text] [Related]
7. Tripartite Motif-Containing 27 Attenuates Liver Ischemia/Reperfusion Injury by Suppressing Transforming Growth Factor β-Activated Kinase 1 (TAK1) by TAK1 Binding Protein 2/3 Degradation.
Chen SY; Zhang HP; Li J; Shi JH; Tang HW; Zhang Y; Zhang JK; Wen PH; Wang ZH; Shi XY; He YT; Hu BW; Yang H; Guo WZ; Zhang SJ
Hepatology; 2021 Feb; 73(2):738-758. PubMed ID: 32343849
[TBL] [Abstract][Full Text] [Related]
8. Dual-specificity phosphatase 14 protects the heart from aortic banding-induced cardiac hypertrophy and dysfunction through inactivation of TAK1-P38MAPK/-JNK1/2 signaling pathway.
Li CY; Zhou Q; Yang LC; Chen YH; Hou JW; Guo K; Wang YP; Li YG
Basic Res Cardiol; 2016 Mar; 111(2):19. PubMed ID: 26891723
[TBL] [Abstract][Full Text] [Related]
9. Six-Transmembrane Epithelial Antigen of the Prostate 3 Deficiency in Hepatocytes Protects the Liver Against Ischemia-Reperfusion Injury by Suppressing Transforming Growth Factor-β-Activated Kinase 1.
Guo WZ; Fang HB; Cao SL; Chen SY; Li J; Shi JH; Tang HW; Zhang Y; Wen PH; Zhang JK; Wang ZH; Shi XY; Pang C; Yang H; Hu BW; Zhang SJ
Hepatology; 2020 Mar; 71(3):1037-1054. PubMed ID: 31393024
[TBL] [Abstract][Full Text] [Related]
10. Regulator of G-protein signaling 14 protects the liver from ischemia-reperfusion injury by suppressing TGF-β-activated kinase 1 activation.
Zhang JK; Ding MJ; Liu H; Shi JH; Wang ZH; Wen PH; Zhang Y; Yan B; Guo DF; Zhang XD; Tao RL; Yan ZP; Zhang Y; Liu Z; Guo WZ; Zhang SJ
Hepatology; 2022 Feb; 75(2):338-352. PubMed ID: 34455616
[TBL] [Abstract][Full Text] [Related]
11. Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury.
Hu J; Zhu XH; Zhang XJ; Wang PX; Zhang R; Zhang P; Zhao GN; Gao L; Zhang XF; Tian S; Li H
J Hepatol; 2016 Jan; 64(1):146-59. PubMed ID: 26334576
[TBL] [Abstract][Full Text] [Related]
12. The dual-specificity phosphatase DUSP14 negatively regulates tumor necrosis factor- and interleukin-1-induced nuclear factor-κB activation by dephosphorylating the protein kinase TAK1.
Zheng H; Li Q; Chen R; Zhang J; Ran Y; He X; Li S; Shu HB
J Biol Chem; 2013 Jan; 288(2):819-25. PubMed ID: 23229544
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin-specific protease 29 attenuates hepatic ischemia-reperfusion injury by mediating TGF-β-activated kinase 1 deubiquitination.
Chen Z; Hu F; Zhang Y; Zhang L; Wang T; Kong C; Hu H; Guo J; Chen Q; Yu B; Liu Y; Zou J; Zhou J; Qiu T
Front Immunol; 2023; 14():1167667. PubMed ID: 37304282
[TBL] [Abstract][Full Text] [Related]
14. MTMR14 protects against hepatic ischemia-reperfusion injury through interacting with AKT signaling in vivo and in vitro.
Li S; Zhang M; Zhang B
Biomed Pharmacother; 2020 Sep; 129():110455. PubMed ID: 32768948
[TBL] [Abstract][Full Text] [Related]
15. Tripartite Motif 8 Deficiency Relieves Hepatic Ischaemia/reperfusion Injury via TAK1-dependent Signalling Pathways.
Tao Q; Tianyu W; Jiangqiao Z; Zhongbao C; Xiaoxiong M; Long Z; Jilin Z
Int J Biol Sci; 2019; 15(8):1618-1629. PubMed ID: 31360105
[TBL] [Abstract][Full Text] [Related]
16. DUSP14 knockout accelerates cardiac ischemia reperfusion (IR) injury through activating NF-κB and MAPKs signaling pathways modulated by ROS generation.
Lin B; Xu J; Feng DG; Wang F; Wang JX; Zhao H
Biochem Biophys Res Commun; 2018 Jun; 501(1):24-32. PubMed ID: 29660332
[TBL] [Abstract][Full Text] [Related]
17. Dual-specificity phosphatase 26 protects against kidney injury caused by ischaemia-reperfusion through restraint of TAK1-JNK/p38-mediated apoptosis and inflammation of renal tubular epithelial cells.
Xiang H; Li Z; Li Y; Zheng J; Dou M; Xue W; Wu X
Toxicol Appl Pharmacol; 2024 Jun; 487():116954. PubMed ID: 38705402
[TBL] [Abstract][Full Text] [Related]
18. USP10 protects against cerebral ischemia injury by suppressing inflammation and apoptosis through the inhibition of TAK1 signaling.
Wang L; Wu D; Xu Z
Biochem Biophys Res Commun; 2019 Sep; 516(4):1272-1278. PubMed ID: 31301769
[TBL] [Abstract][Full Text] [Related]
19. MiR-155-5p accelerates cerebral ischemia-reperfusion injury via targeting DUSP14 by regulating NF-κB and MAPKs signaling pathways.
Shi Y; Li K; Xu K; Liu QH
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1408-1419. PubMed ID: 32096190
[TBL] [Abstract][Full Text] [Related]
20. Alpinetin protects against hepatic ischemia/reperfusion injury in mice by inhibiting the NF-κB/MAPK signaling pathways.
Pan J; Chen S; Guo W; Cao S; Shi X; Zhang J; Zhang H; Zhang S
Int Immunopharmacol; 2021 Jun; 95():107527. PubMed ID: 33743314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
